The surgical mesh implants market size has grown strongly in recent years. It will grow from $3.97 billion in 2025 to $4.24 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing prevalence of hernia and pelvic organ prolapse, advancements in surgical mesh materials, rising hospital infrastructure investment, growth in laparoscopic and open surgeries, demand for cost-effective surgical solutions.
The surgical mesh implants market size is expected to see strong growth in the next few years. It will grow to $5.46 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expansion of robotic-assisted surgery, development of bioabsorbable and hybrid mesh, rising awareness of minimally invasive procedures, growth in geriatrics and chronic disease patients, adoption of personalized surgical solutions. Major trends in the forecast period include minimally invasive surgical techniques adoption, advanced biocompatible materials development, personalized surgical mesh solutions, enhanced post-surgical recovery focus, rising demand for pelvic health solutions.
The increasing adoption of minimally invasive surgeries is expected to drive the growth of the surgical mesh implants market in the coming years. Minimally invasive surgery refers to procedures performed through small incisions, often utilizing laparoscopic or robotic-assisted techniques. The popularity of minimally invasive surgeries is rising due to their ability to enable faster recovery, allowing patients to resume normal activities sooner while minimizing postoperative discomfort and reducing hospital stay durations. As the number of minimally invasive procedures grows, the demand for mesh implants rises in applications such as hernia repair and pelvic surgeries, as these implants are commonly used in such interventions. For example, in January 2025, Intuitive Surgical Inc., a US-based medical device company, reported that in 2024, their products were used in nearly 2.7 million procedures, reflecting a 17% increase compared to 2023. Overall, the cumulative number of procedures performed on da Vinci platforms has now reached almost 17 million. Consequently, the growth of minimally invasive surgeries is fueling the expansion of the surgical mesh implants market.
Key players in the surgical mesh implants sector are focusing on technological advancements, particularly in the development of fully bioabsorbable meshes. These innovations aim to improve patient recovery, reduce long-term complications, and respond to the demand for temporary implant solutions. Fully bioabsorbable meshes are made from materials that naturally break down and are absorbed by the body, eliminating the need for permanent implantation. In April 2025, Becton, Dickinson and Company, a U.S.-based pharmaceutical firm, received FDA 510(k) clearance and commercially launched the Phasix ST Umbilical Hernia Patch in the U.S. This is the first and only fully absorbable mesh specifically designed for umbilical hernia repair. Made from bioabsorbable polymer, the patch dissolves within the body over time, offering a non-permanent and patient-friendly treatment option that aligns with evolving clinical needs.
In February 2024, RTI Surgical Inc., a U.S.-based contract development and manufacturing organization, completed the acquisition of Cook Biotech Inc. for an undisclosed amount. With this acquisition, RTI Surgical aims to become the only regenerative medicine CDMO capable of producing both allograft and xenograft biomaterials on a large scale. This strategic move strengthens its leadership in soft tissue applications and expands its market reach. Cook Biotech Inc. is a U.S.-based company, specializes in regenerative medicine and manufactures biologic mesh products for hernia repair.
Major companies operating in the surgical mesh implants market are Johnson And Johnson, Medtronic plc, W L Gore And Associates Inc, Cook Medical, Integra LifeSciences Corporation, Ethicon Inc, B Braun Melsungen AG, Feg Textiltechnik mbH, Cousin Biotech, Proxy Biomedical Ltd, Betatech Medical, Dipromed Srl, Novus Scientific Pte Ltd, Atrium Medical Corporation, LifeCell Corporation, Hernia Mesh S R L, THT Bio Science Inc, Gore Medical, Bard Medical, Covidien Ltd, Surgical Specialties Corporation, Aspen Surgical Products Inc.
North America was the largest region in the surgical mesh implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical mesh implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical mesh implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the surgical mesh implants market by increasing the cost of imported raw materials and synthetic polymers, impacting manufacturers who rely on global supply chains. The non-absorbable and absorbable mesh segments, particularly in North America and Europe, face higher production costs and pricing pressures. While tariffs may slow market expansion temporarily, they also encourage local manufacturing and innovation in cost-effective mesh materials, which can strengthen regional production capabilities and reduce dependency on imports.
The surgical mesh implants market research report is one of a series of new reports that provides surgical mesh implants market statistics, including surgical mesh implants industry global market size, regional shares, competitors with a surgical mesh implants market share, detailed surgical mesh implants market segments, market trends and opportunities, and any further data you may need to thrive in the surgical mesh implants industry. This surgical mesh implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical mesh implants are medical devices made from either synthetic or biological materials, used to provide additional support to weakened or damaged tissue during surgical procedures. These implants are commonly used in soft tissue reinforcement surgeries and other similar procedures, helping to promote tissue growth and healing while restoring structural integrity.
The primary types of surgical mesh implants include non-absorbable surgical mesh, absorbable surgical mesh, and other variations. Non-absorbable surgical mesh is made from synthetic materials that remain permanently in the body to offer long-term support to weakened or damaged tissue. Surgical procedures employing these meshes include laparoscopic surgery, open surgery, robotic-assisted surgery, and endoscopic surgery. Materials used in surgical mesh implants include polypropylene, polyester, polytetrafluoroethylene, and others. These meshes are applied in various medical procedures such as hernia repair, pelvic organ prolapse repair, and gastroesophageal reflux disease (GERD) repair. They are used by several end users, including hospitals, ambulatory surgical centers (ASCs), specialized clinics, and research institutions.
The surgical mesh implants market consists of sales of plug mesh, coated mesh, lightweight mesh, and heavyweight mesh. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The surgical mesh implants market size is expected to see strong growth in the next few years. It will grow to $5.46 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expansion of robotic-assisted surgery, development of bioabsorbable and hybrid mesh, rising awareness of minimally invasive procedures, growth in geriatrics and chronic disease patients, adoption of personalized surgical solutions. Major trends in the forecast period include minimally invasive surgical techniques adoption, advanced biocompatible materials development, personalized surgical mesh solutions, enhanced post-surgical recovery focus, rising demand for pelvic health solutions.
The increasing adoption of minimally invasive surgeries is expected to drive the growth of the surgical mesh implants market in the coming years. Minimally invasive surgery refers to procedures performed through small incisions, often utilizing laparoscopic or robotic-assisted techniques. The popularity of minimally invasive surgeries is rising due to their ability to enable faster recovery, allowing patients to resume normal activities sooner while minimizing postoperative discomfort and reducing hospital stay durations. As the number of minimally invasive procedures grows, the demand for mesh implants rises in applications such as hernia repair and pelvic surgeries, as these implants are commonly used in such interventions. For example, in January 2025, Intuitive Surgical Inc., a US-based medical device company, reported that in 2024, their products were used in nearly 2.7 million procedures, reflecting a 17% increase compared to 2023. Overall, the cumulative number of procedures performed on da Vinci platforms has now reached almost 17 million. Consequently, the growth of minimally invasive surgeries is fueling the expansion of the surgical mesh implants market.
Key players in the surgical mesh implants sector are focusing on technological advancements, particularly in the development of fully bioabsorbable meshes. These innovations aim to improve patient recovery, reduce long-term complications, and respond to the demand for temporary implant solutions. Fully bioabsorbable meshes are made from materials that naturally break down and are absorbed by the body, eliminating the need for permanent implantation. In April 2025, Becton, Dickinson and Company, a U.S.-based pharmaceutical firm, received FDA 510(k) clearance and commercially launched the Phasix ST Umbilical Hernia Patch in the U.S. This is the first and only fully absorbable mesh specifically designed for umbilical hernia repair. Made from bioabsorbable polymer, the patch dissolves within the body over time, offering a non-permanent and patient-friendly treatment option that aligns with evolving clinical needs.
In February 2024, RTI Surgical Inc., a U.S.-based contract development and manufacturing organization, completed the acquisition of Cook Biotech Inc. for an undisclosed amount. With this acquisition, RTI Surgical aims to become the only regenerative medicine CDMO capable of producing both allograft and xenograft biomaterials on a large scale. This strategic move strengthens its leadership in soft tissue applications and expands its market reach. Cook Biotech Inc. is a U.S.-based company, specializes in regenerative medicine and manufactures biologic mesh products for hernia repair.
Major companies operating in the surgical mesh implants market are Johnson And Johnson, Medtronic plc, W L Gore And Associates Inc, Cook Medical, Integra LifeSciences Corporation, Ethicon Inc, B Braun Melsungen AG, Feg Textiltechnik mbH, Cousin Biotech, Proxy Biomedical Ltd, Betatech Medical, Dipromed Srl, Novus Scientific Pte Ltd, Atrium Medical Corporation, LifeCell Corporation, Hernia Mesh S R L, THT Bio Science Inc, Gore Medical, Bard Medical, Covidien Ltd, Surgical Specialties Corporation, Aspen Surgical Products Inc.
North America was the largest region in the surgical mesh implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical mesh implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical mesh implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the surgical mesh implants market by increasing the cost of imported raw materials and synthetic polymers, impacting manufacturers who rely on global supply chains. The non-absorbable and absorbable mesh segments, particularly in North America and Europe, face higher production costs and pricing pressures. While tariffs may slow market expansion temporarily, they also encourage local manufacturing and innovation in cost-effective mesh materials, which can strengthen regional production capabilities and reduce dependency on imports.
The surgical mesh implants market research report is one of a series of new reports that provides surgical mesh implants market statistics, including surgical mesh implants industry global market size, regional shares, competitors with a surgical mesh implants market share, detailed surgical mesh implants market segments, market trends and opportunities, and any further data you may need to thrive in the surgical mesh implants industry. This surgical mesh implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical mesh implants are medical devices made from either synthetic or biological materials, used to provide additional support to weakened or damaged tissue during surgical procedures. These implants are commonly used in soft tissue reinforcement surgeries and other similar procedures, helping to promote tissue growth and healing while restoring structural integrity.
The primary types of surgical mesh implants include non-absorbable surgical mesh, absorbable surgical mesh, and other variations. Non-absorbable surgical mesh is made from synthetic materials that remain permanently in the body to offer long-term support to weakened or damaged tissue. Surgical procedures employing these meshes include laparoscopic surgery, open surgery, robotic-assisted surgery, and endoscopic surgery. Materials used in surgical mesh implants include polypropylene, polyester, polytetrafluoroethylene, and others. These meshes are applied in various medical procedures such as hernia repair, pelvic organ prolapse repair, and gastroesophageal reflux disease (GERD) repair. They are used by several end users, including hospitals, ambulatory surgical centers (ASCs), specialized clinics, and research institutions.
The surgical mesh implants market consists of sales of plug mesh, coated mesh, lightweight mesh, and heavyweight mesh. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Surgical Mesh Implants Market Characteristics
3. Surgical Mesh Implants Market Supply Chain Analysis
4. Global Surgical Mesh Implants Market Trends and Strategies
5. Surgical Mesh Implants Market Analysis of End Use Industries
7. Global Surgical Mesh Implants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Surgical Mesh Implants Total Addressable Market (TAM) Analysis for the Market
9. Surgical Mesh Implants Market Segmentation
10. Surgical Mesh Implants Market Regional and Country Analysis
11. Asia-Pacific Surgical Mesh Implants Market
12. China Surgical Mesh Implants Market
13. India Surgical Mesh Implants Market
14. Japan Surgical Mesh Implants Market
15. Australia Surgical Mesh Implants Market
16. Indonesia Surgical Mesh Implants Market
17. South Korea Surgical Mesh Implants Market
18. Taiwan Surgical Mesh Implants Market
19. South East Asia Surgical Mesh Implants Market
20. Western Europe Surgical Mesh Implants Market
21. UK Surgical Mesh Implants Market
22. Germany Surgical Mesh Implants Market
23. France Surgical Mesh Implants Market
24. Italy Surgical Mesh Implants Market
25. Spain Surgical Mesh Implants Market
26. Eastern Europe Surgical Mesh Implants Market
27. Russia Surgical Mesh Implants Market
28. North America Surgical Mesh Implants Market
29. USA Surgical Mesh Implants Market
30. Canada Surgical Mesh Implants Market
31. South America Surgical Mesh Implants Market
32. Brazil Surgical Mesh Implants Market
33. Middle East Surgical Mesh Implants Market
34. Africa Surgical Mesh Implants Market
36. Surgical Mesh Implants Market Competitive Landscape and Company Profiles
37. Surgical Mesh Implants Market Other Major and Innovative Companies
40. Surgical Mesh Implants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Surgical Mesh Implants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses surgical mesh implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for surgical mesh implants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical mesh implants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Non-Absorbable Surgical Mesh; Absorbable Surgical Mesh; Other Types2) By Surgical Procedure Type: Laparoscopic Surgery; Open Surgery; Robotic-assisted Surgery; Endoscopic Surgery
3) By Material: Polypropylene; Polyester; Polytetrafluoroethylene; Other Materials
4) By Application: Hernia Repair; Pelvic Organ Prolapse Repair; Gastroesophageal Reflux Disease (GERD) Repair; Other Surgical Applications
5) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics
Subsegments:
1) By Non-Absorbable Surgical Mesh: Polypropylene Mesh; Expanded Polytetrafluoroethylene (ePTFE) Mesh; Polyester Mesh; Composite Mesh2) By Absorbable Surgical Mesh: Polyglycolic Acid (PGA) Mesh; Polylactic Acid (PLA) Mesh; Polyglycolide-co-lactide (PGLA) Mesh; Poly-4-hydroxybutyrate (P4HB) Mesh
3) By Other Types: Biologic Mesh; Hybrid Mesh; Coated/Barrier Mesh; 3D-printed Mesh
Companies Mentioned: Johnson And Johnson; Medtronic plc; W L Gore And Associates Inc; Cook Medical; Integra LifeSciences Corporation; Ethicon Inc; B Braun Melsungen AG; Feg Textiltechnik mbH; Cousin Biotech; Proxy Biomedical Ltd; Betatech Medical; Dipromed Srl; Novus Scientific Pte Ltd; Atrium Medical Corporation; LifeCell Corporation; Hernia Mesh S R L; THT Bio Science Inc; Gore Medical; Bard Medical; Covidien Ltd; Surgical Specialties Corporation; Aspen Surgical Products Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Surgical Mesh Implants market report include:- Johnson And Johnson
- Medtronic plc
- W L Gore And Associates Inc
- Cook Medical
- Integra LifeSciences Corporation
- Ethicon Inc
- B Braun Melsungen AG
- Feg Textiltechnik mbH
- Cousin Biotech
- Proxy Biomedical Ltd
- Betatech Medical
- Dipromed Srl
- Novus Scientific Pte Ltd
- Atrium Medical Corporation
- LifeCell Corporation
- Hernia Mesh S R L
- THT Bio Science Inc
- Gore Medical
- Bard Medical
- Covidien Ltd
- Surgical Specialties Corporation
- Aspen Surgical Products Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.24 Billion |
| Forecasted Market Value ( USD | $ 5.46 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
